Targeting EGFR in glioblastoma with a novel brain-penetrant small molecule EGFR-TKI
J. Ni, Y. Wang, Q. Wang, J. S. Bergholz, T. Jiang, T. M. Roberts, N. S. Gray, J. J. Zhao
This paper introduces a novel EGFR-TKI, CM93, which shows improved brain penetration and efficacy against EGFR-mutated glioblastoma in vitro and in vivo.
bioRxiv · Jan 9, 2021 · PreprintCancer Biology